Check out this detailed presentation on how Nanoforming can help improve the performance of your molecule by increasing drug loads for smaller/fewer pills or long-acting injectables, improving bioavailability, enhancing drug delivery profiles, and supporting product differentiation while boosting patient adherence.
Dr. David Rowe, Head of Manufacturing at Nanoform, provides an overview of Nanoform's manufacturing capabilities and introduces a unique, new, state-of-the-art multimillion euro nanotechnology facility to produce GMP nanoparticles as small as 10 nanometers. Nanoform is the only company in the world to offer this capability.
Through using nanocrystalline formulations of new drugs, and reformulating already-marketed ASD products, this webinar demonstrates how bioavailability of poorly soluble APIs can be improved and patient compliance enhanced by reducing the size or number of tablets that a patient must take to achieve the required dose.
Can your product be NanoImproved? Find out at-a-glance with a 4-page informational spread covering new molecules and reformulations, small molecules and biologics, technology details, and proof points.
